ADC Therapeutics SA (ADCT) vs Nature's Sunshine Products (NATR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nature's Sunshine Products (NATR) has outperformed ADC Therapeutics SA (ADCT) over the past year, losing 16.2% versus a loss of 65.0%. Over five years, NATR leads with a -18.2% price change compared with -93.8% for ADCT. Nature's Sunshine Products is the larger company by market cap ($223.2 million vs $211.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADCT | NATR |
|---|---|---|
| Share price | $1.66 | $12.69 |
| Market cap | $211.93M | $223.20M |
| 1-day change | +4.37% | +0.91% |
| YTD return | -54.96% | -41.75% |
| 1-year return | -64.98% | -16.20% |
| 5-year return | -93.76% | -18.22% |
| P/E ratio (TTM) | — | 12.56 |
| Forward P/E | — | 10.31 |
| EPS (TTM) | $-0.60 | $1.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.98 | $28.14 |
| 52-week low | $0.78 | $12.31 |
| Distance from 52-week high | -66.67% | -54.92% |
| Analyst consensus | none | none |
| Avg. price target upside | +100.60% | +140.44% |
| Average volume | 1.43M | 160.23K |
| Shares outstanding | 127.67M | 17.60M |
| Employees | 188 | 806 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NATR has outperformed ADCT by 48.8 percentage points over the past year.
About ADC Therapeutics SA
ADCT stock →ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S.
Health Care · Biotechnology: Pharmaceutical Preparations · 188 employees
About Nature's Sunshine Products
NATR stock →Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees
ADCT vs NATR FAQ
Which is bigger, ADC Therapeutics SA or Nature's Sunshine Products?
Nature's Sunshine Products (NATR) is larger, with a market capitalization of $223.20M compared with $211.93M for ADC Therapeutics SA (ADCT).
Which stock has performed better over the past year, ADCT or NATR?
NATR returned -16.20% over the past 12 months, compared with -64.98% for ADCT (price return, excluding dividends). Past performance does not predict future results.
Are ADC Therapeutics SA and Nature's Sunshine Products in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.